Completed PHASE1/PHASE2 NCT00730314

Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells

Phase I/II Trial Of Hematopoietic Stem Cell Transplant (HSCT) For Children With A Genetic Disease Of Blood Cells Without An HLA-Matched Sibling Donor

Sponsor: Children's Hospital Los Angeles

Conditions Anemia Chediak Higashi Syndrome Fucosidosis Granuloma Hurler Disease Neutropenia Niemann-Pick Disease Osteopetrosis Sickle Cell Disease Thalassemia Thrombocytopenia Wiskott-Aldrich Syndrome

Interventions Hematopoietic stem cell transplantation

Updated 5 times since 2017 Last updated: Jun 21, 2016 Started: Aug 31, 2008 Primary completion: Aug 31, 2015 Completion: Aug 31, 2015

This PHASE1/PHASE2 trial investigates Anemia and Chediak Higashi Syndrome and is currently completed. Children's Hospital Los Angeles leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital Los Angeles

Data source: Children's Hospital Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States